Oberoi Realty. CMP: INR269 TP: INR320 Buy

Similar documents
Oberoi Realty. CMP: INR264 TP: INR315 Buy

Unitech. CMP: INR20 TP: INR30 Buy

Jubilant Foodworks. CMP: INR1,189 TP: INR1,0541,054 Neutral

Pidilite Industries. CMP: INR164 TP: INR186 Buy

BGR Energy. CMP: INR266 TP: INR230 Neutral

NTPC CMP: INR169 TP: INR191 Buy

Titan Industries. CMP: INR222 TP: INR220 Neutral

BGR Energy. CMP: INR282 TP: INR253 Neutral

Godrej Properties. CMP: INR595 TP: INR635 Neutral

Canara Bank. CMP: INR419 TP: INR525 Buy

Hardick Bora

Phoenix Mills. CMP: INR184 TP: INR255 Buy

Idea Cellular. CMP: INR81 TP: INR Under Review

Asian Paints. CMP: INR2,722 TP: INR3,161 Buy

Sandipan Pal QFY13 Results Update Sector: Real Estate Unitech CMP: INR29 TP: INR44 Buy

Larsen & Toubro. CMP: INR1,160 TP: INR1,417 Buy

Godrej Consumer Products

IndusInd Bank. CMP: INR345 TP: INR419 Buy

Oberoi Realty. CMP: INR240 TP: INR297 Buy

Reliance Infrastructure CMP: INR528

Sanjay Jain Pavas Pethia

Punjab National Bank. CMP: INR716 TP: INR950 Buy

M&M Financial Services

BGR Energy. CMP: INR284 TP: INR296 Neutral

Cummins India. CMP: INR430 TP: INR462 Neutral

Punjab National Bank. CMP:INR1,103 TP:INR1,500 Buy

Sanofi India. CMP: INR2,200 TP: INR1,848 Neutral

CMP: INR121 TP: INR193 Buy

Shree Renuka Sugars. CMP: INR26 TP: INR45 Buy

Kotak Mahindra Bank. CMP: INR495 TP: INR429 Neutral

Niket Shah

Sohail Halai Alpesh Mehta

CMP: INR415 TP: INR 471 BUY

IDBI Bank. CMP: INR106 TP: INR121 Neutral

Coal India CMP: INR348 TP: INR408 Buy

Jaypee Infratech. CMP: INR33 TP: INR45 Buy

Petronet LNG. CMP: INR146 TP: INR205 Buy

Strides Arcolab. CMP: INR717 TP: INR829 Buy

Kotak Mahindra Bank. CMP: INR626 TP: INR500 Neutral

Godrej Properties. CMP: INR368 TP: INR420 Neutral

Jaiprakash Associates

Hindalco. CMP: INR113 TP: INR151 Buy

Larsen & Toubro. CMP: INR1,278 TP: INR1,380 Buy

Godawari Power & Ispat

Siddharth Bothra

Canara Bank. CMP: INR464 TP: INR645 Buy

Jinesh Gandhi Sandipan Pal

Jubilant Foodworks. CMP: INR1,051 TP: INR1,054 Neutral

Dabur India. CMP: INR130 TP: INR135 Neutral

CMP: INR350 TP: INR375 Downgrade to Neutral

Steel Authority of India

Idea Cellular. CMP: INR159 TP: INR200 Buy

Maruti Suzuki. CMP: INR1,395 TP: INR1,730 Buy

Stress test: Weak capital servicing ratios to drive pricing discipline

Axis Bank. CMP: INR1,119 TP: INR1,330 Buy

JSW Steel. CMP: INR670 TP: INR391 Sell Merger with JSW Ispat

Dabur India. CMP: INR106 TP: INR94 Neutral

Hardick Bora 4QCY12 Results Update Sector: Healthcare Sanofi India CMP: INR2,307 TP: INR2,015 Neutral

Jinesh Gandhi Chirag Jain

Punjab National Bank. CMP: INR940 TP: INR1,275 Buy

Monnet Ispat. CMP: INR449 TP: INR518 Neutral

Punjab National Bank. CMP: INR768 TP: INR963 Buy

Godrej Consumer Products

Axis Bank. CMP: INR1,008 TP: INR1,240 Buy

Prestige Estates. CMP: INR169 TP: INR195 Buy FY13 sales booking to beat guidance by ~20%

Urban demand revives; Akzo gaining market share

Hindustan Unilever. CMP:INR324 TP:INR302 Neutral

BHEL. CMP: INR227 TP: INR233 Neutral

Cement. Demand to grow 8%, with cost push to be passed on CCI probe to have limited impact

Birla Corporation. CMP: INR216 TP: INR277 Buy

Alpesh Mehta Sohail Halai

Hardick Bora QFY13 Results Update Sector: Healthcare Lupin CMP: INR725 TP: INR851 Buy

Just Dial. CMP: INR1,129 TP: INR1,475 Buy

Hardick Bora 4QFY13 Results Update Sector: Healthcare Dr Reddy's Laboratories CMP: INR2,026 TP: INR2,375 Buy

Raymond. Restructuring initiatives bearing fruit; Land bank base case value INR147/share; Reiterate Buy. CMP: INR385 TP: INR462 Buy

Sun Pharmaceuticals. CMP: INR554 TP: INR614 Neutral

Shoppers Stop. CMP: INR339 TP: INR355 Neutral

Pantaloon Retail. CMP: INR177 TP: INR192 Neutral

Shree Renuka Sugars. CMP: INR41 TP: INR50 Buy

Market share recovery, price hike, content leverage to drive growth

Amara Raja Batteries. CMP: INR517 TP: INR560 Buy

Cross service charges at INR m/quarter

Thermax. CMP: INR522 TP: INR414 Neutral

Punjab National Bank. CMP: INR760 TP: INR964 Buy Asset quality deteriorates; asset-liability well-matched Highlights of FY12 Annual Report

Tata Power. CMP: INR111 TP: INR92 Neutral

Jinesh Gandhi Chirag Jain

ITC. CMP: INR201 TP: INR230 Buy

CMP: INR401 TP: INR516 Buy. * After ESOP charges; # Axon consolidated in December 2008

CPCB-2: Important long-term driver

Jinesh Gandhi Sandipan Pal

Coal India. CMP: INR322 TP: INR370 Buy

Jinesh Gandhi Sandipan Pal

Godrej Consumer Products

Gautam Duggad Sreekanth P V S

Torrent Pharmaceuticals

Maruti Suzuki. CMP:Rs1,327 TP:Rs1,625 Buy

Tribhovandas Bhimji Zaveri

ECOSCOPE. Real GDP growth eases on lower net indirect taxes. The Economy Observer. Real GVA growth exactly as expected

Cummins India. Profitability supported by cost optimization measures. CMP: INR449 TP: INR432 Neutral

Shriram Transport Finance

Transcription:

BSE SENSEX S&P CNX 18,682 5,684 Bloomberg OBER IN Equity Shares (m) 328.2 52-Week Range (INR) 323/205 1,6,12 Rel. Perf. (%) 13/-7/7 M.Cap. (INR b) 88.3 M.Cap. (USD b) 1.6 22 October 2012 2QFY13 Results Update Sector: Real Estate CMP: INR269 TP: INR320 Buy (OBER IN) reported 2QFY13 results above our estimates. Revenues stood at INR2.6b (v/s est of INR2.1b), up 16% YoY/29% QoQ. Higher revenue booking is attributable to better-than-expected construction progress in Exquisite (6% QoQ v/s 4% in 1QFY13) and Grande (13% QoQ v/s 7% in 1QFY13) and higher sales at Splendor. Rental income from Commerz, Oberoi Mall and Hotel Westin accounted for ~INR518m (down 5% QoQ). Hotel Westin witnessed 5% QoQ decline in revenues, led by a seasonal weakness, albeit up 10% YoY, along with ~8.6pp YoY increase (down 1.7pp QoQ) in occupancy and 7.1pp YoY uptick (down 2.9pp QoQ) in EBITDA margins. EBITDA grew 19.5% YoY to INR1.5b, while margins were up 1.1pp/6.2pp QoQ/YoY to 58.1%. Core EBITDA (ex hotel) was stable QoQ at 61%. PAT grew 11.6% YoY to INR1.2b due to lower other income (due to a decline in cash balance at INR11.1b). Sales momentum improved marginally to 0.13msf (INR2.2b) v/s 0.12msf (INR2.1b) in 1QFY13. Esquire accounted for ~50% of sales value. Average realizations stood at INR17,077/sf (up 2% QoQ, 37% YoY), led by the double 10% price hikes taken in FY12. We are estimating sales estimate of 1msf (INR14b) for FY13, which assumes the launch of Mulund and Worli projects. Customer collections are down across projects to INR1.6b v/s INR2.3b in 1QFY12 and INR2.9b in 2QFY12, which led to negative operational cash flow of INR580m v/s +INR604m in 1QFY13. Weak collections are due to (1) decline in collection pace at Grande and Exquisite (as these projects have already reached slab casting stage and the typical Oberoi's aggressive collection curve peaks out here) and (2) slower execution in Esquire due to pending construction approvals (a key risk to our FY13 revenue estimate as Esquire's recognition may be delayed till 1QFY14). Going forward, we believe the key to cash flow uptick would be driven by (1) new launches (2) progress in Esquire and (3) incremental sales in ongoing projects, as collections from pre-sales of Exquisite and Grande would remain weak. Sandipan Pal (Sandipan.Pal@MotilalOswal.com); +9122 3982 5436 Investors are advised to refer through disclosures made at the end of the Research Report. 1

Key results highlights Revenue booking above estimate led by stronger execution progress; INR16b unrecognized order book 2QFY13 revenues stood at INR2.6b (v/s est of INR2.1b), up 16% YoY/29% QoQ. Key contributors are: (1) Exquisite (38%), (2) Grande (27%), (3) Completed projects (Splendor 11%) and (4) Annuity projects (20%). The higher revenue booking is attributable to better-than-expected construction progress in Exquisite (6% QoQ v/s 4% in 1QFY13) and Grande (13% QoQ v/s 7% in 1QFY13) and higher sales at Splendor. The better execution progress is attributable to the nature of work (more of internal finishing and post slab casting works) being done in both Grande and Exquisite, which typically have faster turnaround time and are not impacted by monsoon. Oberoi Esquire (with ~50% sales contribution in 2QFY13) is yet to cross the revenue recognition threshold of 25%. Its current unrecognized order book stood at INR16b (including INR11b from Esquire), thus rendering strong revenue visibility over the forthcoming quarters (expect one-off jump in 4QFY13/1QFY14 with Esquire expected to generate revenues). Annuity income down QoQ, led by seasonally weaker hotel operations; occupancy, margins improve YoY Rental income from Commerz, Oberoi Mall and Hotel Westin accounted for ~INR518m (down 5% QoQ). Hotel Westin witnessed a 5% QoQ decline in revenues led by seasonal weakness, albeit up 10% YoY, along with ~8.6pp YoY increase (down 1.7pp QoQ) in occupancy and 7.1pp YoY uptick (down 2.9pp QoQ) in EBITDA margins. We estimate FY13/FY14 rental income at INR2.2b (stable YoY)/INR2.9b, assuming Commerz II to start operations in 4QFY13-end, where the façade work is in progress and management has guided for strong leasing transactions in the pipeline. Core EBITDA margins down 600bp EBITDA grew 19.5% YoY to INR1.5b, while EBITDA margins were up 1.1pp QoQ and 6.2pp YoY to 58.1%. Core EBITDA (ex hotel) was stable QoQ at 61% but down YoY (from 65% in 2QFY12) on account of the change in project mix and cost escalations at Exquisite and Grande. PAT grew 11.6% YoY to INR1.2b due to lower other income (a decline in cash balance at INR11.1b v/s INR13.5b in 1HFY12). Sales, realizations marginally up QoQ Sales momentum has improved marginally to 0.13msf (INR2.2b) v/s 0.12msf (INR2.1b) in 1QFY13 and 0.19msf (INR2.3b) in 2QFY12. Esquire accounted for ~50% of sales value. Average realizations stood at INR17,077/ sf (up 2% QoQ, 37% YoY), led by the double 10% price hikes taken in FY12. Downside risks to our sales estimate for FY13 of 1msf (INR14b) would depend on absence of any new launch (Mulund/Worli/Garden City Phase III). 22 October 2012 2

Collections deteriorate QoQ due to maturing collection curve at Exquisite and Grande Customer collections are down across projects to INR1.6b v/s INR2.3b in 1QFY12 and INR2.9b in 2QFY12. Oberoi typically has aggressive payment plan and it collects almost 40% at booking. Thus, the company has a steeper construction-linked collection curve which reaches almost 85-90% by the time it completes 60-70% of the construction work (till completion of slab casting). Post this stage, the construction-linked payment pace declines significantly. Thus, weak collections in 2QFY13 is on account of (1) decline in the collection pace at Grande and Exquisite (reached post slab casting stage) and (2) slower execution in Esquire due to pending construction approvals. We believe, going forward, the key to cash flow uptick would be driven by (1) new launches, (2) progress in Esquire and (3) incremental sales in ongoing projects, as collections from pre-sales of Exquisite and Grande would remain weak. Lower collection has resulted into operational cash flow of negative INR580m v/s +INR604m in 1QFY13. Cash flow weakness due to lower collections Cash flow estimates 1QFY13 2QFY13 Remarks Collections 2,260 1,563 Collection deteriorated Rent (at EBITDA) 353 343 Hotel seasonally weak Other income 309 250 Lower due to decline in cash balance Tax 368 541 Higher due to higher PBT, including DDT Admin expense 163 171 Stable QoQ Capex project 380 377 Stable QoQ Construction cost 1,478 1,774 Including purchase of TDR of INR1b Operating Cashflow 604 (580) Cash flownegative due to lower collections Investing cash flow (605) (480) Capex, Other income and land advances Financing cash flow (107) (657) Payment fo Dividend of INR2/share Net Cashflow (107) (1,716) Source: Company, MOSL Other updates Construction progress in Prism remains slow (spent INR10m in 2QFY13) broadly due to sluggish commercial market outlook, while it has spent almost INR570m in Worli projects, which has witnessed considerable progress in construction before official launches. Commerz II (Phase I) is expected to start operations at 4QFY13 with façade work in progress. The company has spent ~INR380m among both phases of Commerz in 2QFY13. The management has guided for higher focus on residential vertical on the back of weakness in commercial demand. It plans to change a meaningful portion of commercial area at JVLR project residential. 22 October 2012 3

Valuation and view: Re-leveraging, cash deployment key to restore high RoCE Despite the sluggishness in Mumbai market, Oberoi has been able to hold a stable sales momentum due to strong product propositions, smart pricing and superior customer preference. Oasis (Worli) is witnessing strong response at the pre-sales stage and we expect the official launch in 3QFY13. This along with the long pending MoEF approval in Mulund project would be key factors to protect downside risks to our sales estimate. Strong balance sheet with INR11.1b of idle cash renders competitive advantage in a liquidity strapped environment. But delays in deployment of surplus cash in value-accretive projects have been an overhang on RoCE and could dilute the advantage if broad-based liquidity improves. So far, the company has been a strong defensive bet due to the high cash surplus and existing annuity assets (~40% of market cap), thus rendering resilience to downcycle risks. Going forward, deployment of cash in attractive projects and new launches would be the key drivers of the stock price. Concern over leasing at near-completed commercial projects is another factor to be seen. The stock is trading at 10.9x FY14E EPS, 1.8x FY14E BV and ~21% discount to our NAV of INR337. Maintain Buy with a target price of INR320. 22 October 2012 4

Sales improves marginally QoQ (msf) Realizations up 2%QoQ (INR/sf) EBITDA Margin up marginally (%) Sales up volume trend across key ongoing projects Construction progress impressive in 2QFY13 Customer collection declines QoQ Annuity income down (INR m) with weaker seasonality effect in Westin hotel (INR m) Source: Company/MOSL 22 October 2012 5

: an investment profile Company description Limited is a Mumbai-based real estate developer. It was incorporated in May 1998 as Kingston Properties Private Ltd. ORL s primary focus is to develop residential property but it has diversified into retail, commercial, hospitality and social infrastructure projects. ORL has undertaken ~5msf of RE development across 35 projects so far. Key investment arguments ORL has a strong brand in Mumbai s RE market due to its (1) diversified products, (2) superior product quality and (3) management goodwill, which enable it to command a pricing premium over peers. ORL is expected to successfully monetize its land bank over 6-7 years as its healthy cash position and hassle-free land imply certainty of execution. This provides high cash flow visibility, adding to its net cash surplus of ~INR13b. ORL enjoys steady cash flow from its annuity assets, which insulates it from vagaries of the RE cycle. Recent developments Customer collections are down across projects to INR1.6b v/s INR2.3b in 1QFY12 and INR2.9b in 2QFY12. Sales momentum has improved marginally to 0.13msf (INR2.2b) v/s 0.12msf (INR2.1b) in 1QFY13 and 0.19msf (INR2.3b) in 2QFY12. Valuation and view The stock is trading at 10.9x FY14E EPS, 1.8x FY14E BV and ~21% discount to our NAV of INR337. Maintain Buy with a target price of INR320. Sector view RE sector has been a major underperformer over the last 12 months with multiple operational and nonoperational headwinds such as volume slowdown (due to declining affordability), monetary tightening, pilling liquidity pressure etc. However, with a buoyant macro-picture, likelihood of interest rate cut and increasing focus on execution, we believe the outlook will improve going forward. Key investment risks Land acquisition challenges due to high cost of land in Mumbai. Idle cash for long time could impact RoE Sluggish Mumbai market. Comparative valuations Oberoi Indiabulls Phoenix P/E (x) FY13E 17.3 14.8 24.1 FY14E 10.9 10.3 11.7 P/BV (x) FY13E 2.1 0.4 1.5 FY14E 1.8 0.4 1.4 EV/Sales (x) FY13E 7.0 2.9 9.8 FY14E 4.2 2.3 4.7 EV/EBITDA (x) FY13E 12.3 10.3 16.8 FY14E 7.1 8.1 9.9 EPS: MOSL forecast v/s consensus (INR) MOSL Consensus Variation Forecast Forecast (%) FY13 15.5 20.3-23.8 FY14 24.7 29.6-16.7 Target Price and Recommendation Current Target Upside Reco. Price (INR) Price (INR) (%) 269 320 19 Buy Stock performance Shareholding pattern (%) Sep-12 Jun-12 Sep-11 Promoter 78.5 78.5 78.5 Domestic Inst 0.9 0.7 1.4 Foreign 19.5 19.8 19.1 Others 1.1 1.0 1.1 22 October 2012 6

Financials and Valuations 22 October 2012 7

Disclosures This report is for personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. This research report does not constitute an offer, invitation or inducement to invest in securities or other investments and Motilal Oswal Securities Limited (hereinafter referred as MOSt) is not soliciting any action based upon it. This report is not for public distribution and has been furnished to you solely for your information and should not be reproduced or redistributed to any other person in any form. Unauthorized disclosure, use, dissemination or copying (either whole or partial) of this information, is prohibited. The person accessing this information specifically agrees to exempt MOSt or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and agrees not to hold MOSt or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSt or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. The information contained herein is based on publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, MOSt and/or its affiliates are under no obligation to update the information. Also there may be regulatory, compliance, or other reasons that may prevent MOSt and/or its affiliates from doing so. MOSt or any of its affiliates or employees shall not be in any way responsible and liable for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. MOSt or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and non-infringement. The recipients of this report should rely on their own investigations. This report is intended for distribution to institutional investors. Recipients who are not institutional investors should seek advice of their independent financial advisor prior to taking any investment decision based on this report or for any necessary explanation of its contents. MOSt and/or its affiliates and/or employees may have interests/positions, financial or otherwise in the securities mentioned in this report. To enhance transparency, MOSt has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. Disclosure of Interest Statement 1. Analyst ownership of the stock No 2. Group/Directors ownership of the stock No 3. Broking relationship with company covered No 4. Investment Banking relationship with company covered No Analyst Certification The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. The research analysts, strategists, or research associates principally responsible for preparation of MOSt research receive compensation based upon various factors, including quality of research, investor client feedback, stock picking, competitive factors and firm revenues. Regional Disclosures (outside India) This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSt & its group companies to registration or licensing requirements within such jurisdictions. For U.K. This report is intended for distribution only to persons having professional experience in matters relating to investments as described in Article 19 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (referred to as "investment professionals"). This document must not be acted on or relied on by persons who are not investment professionals. Any investment or investment activity to which this document relates is only available to investment professionals and will be engaged in only with such persons. For U.S. MOSt is not a registered broker-dealer in the United States (U.S.) and, therefore, is not subject to U.S. rules. In reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S., Motilal Oswal has entered into a chaperoning agreement with a U.S. registered broker-dealer, Marco Polo Securities Inc. ("Marco Polo"). Any business interaction pursuant to this report will have to be executed within the provisions of this Chaperoning agreement. This report is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must not be acted on or relied on by persons who are not major institutional investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only with major institutional investors. The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer, Marco Polo and therefore, may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account. Motilal Oswal Securities Ltd Motilal Oswal Tower, Level 9, Sayani Road, Prabhadevi, Mumbai 400 025 Phone: +91 22 3982 5500 E-mail: reports@motilaloswal.com